AU2019902518A0 - Immuno-oncology therapy - Google Patents
Immuno-oncology therapyInfo
- Publication number
- AU2019902518A0 AU2019902518A0 AU2019902518A AU2019902518A AU2019902518A0 AU 2019902518 A0 AU2019902518 A0 AU 2019902518A0 AU 2019902518 A AU2019902518 A AU 2019902518A AU 2019902518 A AU2019902518 A AU 2019902518A AU 2019902518 A0 AU2019902518 A0 AU 2019902518A0
- Authority
- AU
- Australia
- Prior art keywords
- immuno
- oncology therapy
- oncology
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000002619 cancer immunotherapy Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020217041359A KR20220035038A (en) | 2019-07-17 | 2020-07-16 | Immuno-oncology therapy using isoflavone compounds |
PCT/AU2020/050730 WO2021007618A1 (en) | 2019-07-17 | 2020-07-16 | Immuno-oncology therapy using isoflavone compounds |
CN202080049652.8A CN114072140A (en) | 2019-07-17 | 2020-07-16 | Immune tumor treatment using isoflavones |
MX2021015418A MX2021015418A (en) | 2019-07-17 | 2020-07-16 | Immuno-oncology therapy using isoflavone compounds. |
EP20839686.1A EP3999052A4 (en) | 2019-07-17 | 2020-07-16 | Immuno-oncology therapy using isoflavone compounds |
BR112021026559A BR112021026559A2 (en) | 2019-07-17 | 2020-07-16 | Immuno-oncology therapy using isoflavone compounds |
JP2022502546A JP2022541218A (en) | 2019-07-17 | 2020-07-16 | Cancer immunotherapy using isoflavone compounds |
AU2020313090A AU2020313090A1 (en) | 2019-07-17 | 2020-07-16 | Immuno-oncology therapy using isoflavone compounds |
CA3139314A CA3139314A1 (en) | 2019-07-17 | 2020-07-16 | Immuno-oncology therapy using isoflavone compounds |
US17/324,927 US20210275493A1 (en) | 2019-07-17 | 2021-05-19 | Immuno-oncology therapy using isoflavone compounds |
IL289708A IL289708A (en) | 2019-07-17 | 2022-01-09 | Immuno-oncology therapy using isoflavone compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2019902518A0 true AU2019902518A0 (en) | 2019-08-01 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3768258A4 (en) | Combination therapy | |
EP3873530A4 (en) | Therapeutic methods | |
EP3781482A4 (en) | Nano-satellite | |
EP3867745A4 (en) | Hyperpiler | |
EP3833739A4 (en) | Akkermansia muciniphila | |
EP3893874A4 (en) | Crenolanib combination therapy | |
EP3976107A4 (en) | Sonosensitization | |
GB201900702D0 (en) | Therapy | |
EP3976100A4 (en) | Combination therapy | |
EP4003420A4 (en) | Il-38-specific antiobodies | |
EP3942061A4 (en) | Tumor-selective combination therapy | |
AU2019902518A0 (en) | Immuno-oncology therapy | |
EP3801506A4 (en) | Combination therapy | |
EP3993806A4 (en) | Thiarabine- and thiarabine prodrug-based treatments | |
EP3923980A4 (en) | Cancer therapy | |
AU2019900181A0 (en) | Treatment | |
EP3990820A4 (en) | Cryosphere | |
EP3760209A4 (en) | Ischemic-lesion-site-specific gene therapy | |
AU2021900742A0 (en) | Combination therapy | |
AU2021900459A0 (en) | Combination therapy | |
GB201919036D0 (en) | Therapy | |
AU2019904806A0 (en) | Fastcast-3 | |
AU2020902090A0 (en) | Combination therapy | |
AU2019904733A0 (en) | Trolleyon | |
AU2019904564A0 (en) | WaterWords |